Edition:
United States

Calyxt Inc (CLXT.OQ)

CLXT.OQ on NASDAQ Stock Exchange Global Market

6.91USD
22 Aug 2019
Change (% chg)

-- (--)
Prev Close
$6.91
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
22,603
52-wk High
$19.28
52-wk Low
$6.09

Latest Key Developments (Source: Significant Developments)

Calyxt Reports Second Quarter Loss Per Share Of $0.29
Tuesday, 6 Aug 2019 08:45pm EDT 

Aug 6 (Reuters) - Calyxt Inc ::CALYXT REPORTS 2ND QUARTER FINANCIAL RESULTS.Q2 REVENUE $408,000.Q2 REVENUE ESTIMATE $1.9 MILLION -- REFINITIV IBES DATA.QTRLY LOSS PER SHARE $0.29.  Full Article

Calyxt Reiterates 2019 Guidance And Gives Business Update During June 25 Investor Day
Tuesday, 25 Jun 2019 09:27am EDT 

June 25 (Reuters) - Calyxt Inc ::CALYXT REITERATES 2019 GUIDANCE AND GIVES BUSINESS UPDATE DURING JUNE 25 INVESTOR DAY.SEES FY 2019 REVENUE $7.0 MILLION TO $8.0 MILLION.AFFIRMATION OF 2019 GUIDANCE.  Full Article

Calyxt Reports 1St Quarter Financial Results
Tuesday, 7 May 2019 05:30pm EDT 

May 7 (Reuters) - Calyxt Inc ::CALYXT REPORTS 1ST QUARTER FINANCIAL RESULTS.CASH AND CASH EQUIVALENTS OF $85.7M AT MARCH 31, 2019.QTRLY LOSS PER SHARE $0.23.Q1 EARNINGS PER SHARE VIEW $-0.27 -- REFINITIV IBES DATA.EXPECT TO HAVE SUFFICIENT CASH TO FUND THE BUSINESS INTO EARLY 2021..  Full Article

Calyxt Announces Appointment Of New CFO, Bill Koschak
Monday, 11 Mar 2019 04:10pm EDT 

March 11 (Reuters) - Calyxt Inc ::CALYXT REPORTS 4TH QUARTER AND FULL YEAR 2018 FINANCIAL RESULTS.APPOINTMENT OF NEW CFO, BILL KOSCHAK.CASH, CASH EQUIVALENTS AND RESTRICTED CASH WERE $95.3 MILLION AT DECEMBER 31, 2018.ANTICIPATE CO'S OPERATING CASH SPEND WILL BE ABOUT $3 MILLION PER MONTH ON AVERAGE IN 2019.CO COMPLETED A CONSULTATION WITH THE FOOD AND DRUG ADMINISTRATION (FDA) FOR ITS HIGH OLEIC SOYBEAN.FDA HAD NO FURTHER QUESTIONS CONCERNING HUMAN FOOD INGREDIENTS OR ANIMAL FOOD DERIVED FROM OUR HIGH OLEIC SOYBEAN.  Full Article

Calyxt Appoints Veteran Finance Executive, William F. Koschak, As CFO
Thursday, 3 Jan 2019 04:30pm EST 

Jan 3 (Reuters) - Calyxt Inc ::CALYXT APPOINTS VETERAN FINANCE EXECUTIVE, WILLIAM F. KOSCHAK, AS CHIEF FINANCIAL OFFICER.CALYXT INC - KOSCHAK WILL BE ASSUMING RESPONSIBILITIES OF CURRENT INTERIM CFO, ERIC DUTANG.  Full Article

Calyxt Inc - QTRLY Loss Per Share $0.23
Tuesday, 13 Nov 2018 04:30pm EST 

Calyxt Inc ::CALYXT REPORTS FINANCIAL RESULTS FOR THIRD QUARTER 2018.CASH AND CASH EQUIVALENTS WERE $101.8 MILLION AT SEPTEMBER 30, 2018.EXPECT TO HAVE SUFFICIENT CASH TO FUND BUSINESS UNTIL LATE 2020.ANTICIPATE THAT OPERATING CASH SPEND WILL BE IN RANGE OF $2.0 MILLION PER MONTH ON AVERAGE IN 2018.QTRLY LOSS PER SHARE $0.23.Q3 EARNINGS PER SHARE VIEW $-0.29 -- THOMSON REUTERS I/B/E/S.QTRLY REVENUE $27,000 VERSUS $44,000.  Full Article

Calyxt Inc Says On June 15, Bryan Corkal Resigned As Chief Financial Officer
Thursday, 21 Jun 2018 05:33pm EDT 

June 21 (Reuters) - Calyxt Inc ::CALYXT INC SAYS ON JUNE 15, BRYAN CORKAL RESIGNED AS CHIEF FINANCIAL OFFICER OF CO - SEC FILING.CALYXT - ON JUNE 21, 2018, BOARD APPOINTED ERIC DUTANG AS INTERIM CHIEF FINANCIAL OFFICER OF CO, EFFECTIVE IMMEDIATELY.CALYXT INC - INTENDS TO CONDUCT A SEARCH FOR A PERMANENT CHIEF FINANCIAL OFFICER.  Full Article

Calyxt Reports Q1 Loss Per Share Of $0.16
Monday, 7 May 2018 04:30pm EDT 

May 7 (Reuters) - Calyxt Inc ::CALYXT REPORTS FINANCIAL RESULTS FOR FIRST QUARTER 2018.CALYXT INC QTRLY LOSS PER SHARE $0.16.EXPECT TO HAVE SUFFICIENT CASH TO FUND BUSINESS FOR A SIGNIFICANT PORTION OF 2019.SEES 2018 OPERATING CASH SPEND IN RANGE OF $2.0 MILLION TO $2.2 MILLION PER MONTH EXCLUDING WORKING CAPITAL FOR GRAIN PURCHASES IN LATER PART OF 2018.  Full Article

Calyxt reports qtrly ‍basic and diluted loss per share $0.51​
Monday, 13 Nov 2017 04:29pm EST 

Nov 13 (Reuters) - Calyxt Inc :Calyxt reports financial results for third quarter and first nine months of 2017.Calyxt Inc - ‍Expect current cash position to be sufficient to fund operations through mid-2019​.Calyxt Inc - Qtrly ‍basic and diluted loss per share $0.51​.Q3 earnings per share view $-0.14 -- Thomson Reuters I/B/E/S.  Full Article